From the experience of treating diabetic patients by continuous subcutaneous insulin infusion during past 12 years, the clinical aspects of continuous subcutaneous insulin infusion therapy in the general hospital setting are summarized. For
selection of
patients, motivation for the normal glucose control, responsibility, intelligence and financial support ability are considered. All patients are hospitalized and educated intensively about the basic knowledge of diabetes mellitus, home blood
glucose
monitoring, handling technique of insulin pump, exercise and diet therapy. The blood glucose levels fall from 363.1±42.0(mean SD)mg/dl to 128.7±18.6mg/dl after two weeks' treatment of continuous subcutaneous insulin infusion. Glycosylated
hemoglobin
levels fall from 10.82±2.52% to 6.01±1.68% after three months' treatment. Eighty-six percent of patients experience well-being sensation after five days' continuous subcutaneous insulin infusion treatment. Twenty-eight percent of patients are
in
remission state after 1 year's continuous subcutaneous insulin infusion treatment.
It is concluded that the continuous subcutaneous insulin infusion treatment is effective for the normalization of blood glucose, the prevention of diabetic complications, and good health maintenance for selected diabetic patients.
|